Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2426036
Max Phase: Preclinical
Molecular Formula: C30H52O4
Molecular Weight: 476.74
Molecule Type: Small molecule
Associated Items:
ID: ALA2426036
Max Phase: Preclinical
Molecular Formula: C30H52O4
Molecular Weight: 476.74
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)(O)[C@H]1CC[C@@](C)([C@H]2CC[C@]3(C)[C@@H]2[C@H](O)C[C@@H]2[C@@]4(C)CC[C@H](O)C(C)(C)[C@@H]4CC[C@]23C)O1
Standard InChI: InChI=1S/C30H52O4/c1-25(2)20-10-15-28(6)21(27(20,5)13-11-22(25)32)17-19(31)24-18(9-14-29(24,28)7)30(8)16-12-23(34-30)26(3,4)33/h18-24,31-33H,9-17H2,1-8H3/t18-,19+,20-,21+,22-,23+,24-,27-,28+,29+,30-/m0/s1
Standard InChI Key: DOAJFZJEGHSYOI-LEJKDQSTSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 476.74 | Molecular Weight (Monoisotopic): 476.3866 | AlogP: 5.71 | #Rotatable Bonds: 2 |
Polar Surface Area: 69.92 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.55 | CX LogD: 4.55 |
Aromatic Rings: 0 | Heavy Atoms: 34 | QED Weighted: 0.48 | Np Likeness Score: 3.18 |
1. Zhou Z, Ma C, Zhang H, Bi Y, Chen X, Tian H, Xie X, Meng Q, Lewis PJ, Xu J.. (2013) Synthesis and biological evaluation of novel ocotillol-type triterpenoid derivatives as antibacterial agents., 68 [PMID:23994872] [10.1016/j.ejmech.2013.07.041] |
2. Li L, Chen X, Li D, Zhong D.. (2011) Identification of 20(S)-protopanaxadiol metabolites in human liver microsomes and human hepatocytes., 39 (3): [PMID:21139039] [10.1124/dmd.110.036723] |
3. Ren Q, Yang G, Guo M, Guo J, Li Y, Lu J, Yang Q, Tang H, Li Y, Fang X, Sun Y, Qi JG, Tian J, Wang H.. (2019) Design, synthesis, and discovery of ocotillol-type amide derivatives as orally available modulators of P-glycoprotein-mediated multidrug resistance., 161 [PMID:30347326] [10.1016/j.ejmech.2018.10.038] |
4. Sun Y, Fang X, Gao M, Wang C, Gao H, Bi W, Tang H, Cui Y, Zhang L, Fan H, Yu H, Yang G.. (2020) Synthesis and Structure-Activity Relationship of Pyxinol Derivatives as Novel Anti-Inflammatory Agents., 11 (4): [PMID:32292550] [10.1021/acsmedchemlett.9b00562] |
5. Cheng Y,Li R,Lin Z,Chen F,Dai J,Zhu Z,Chen L,Zhao Y. (2020) Structure-activity relationship analysis of dammarane-type natural products as muscle-type creatine kinase activators., 30 (17.0): [PMID:32738969] [10.1016/j.bmcl.2020.127364] |
6. Wang C,Gao M,Liu S,Zou Z,Ren R,Zhang C,Xie H,Sun J,Qi Y,Qu Q,Song Z,Yang G,Wang H. (2021) Pyxinol bearing amino acid residues: Easily achievable and promising modulators of P-glycoprotein-mediated multidrug resistance., 216 [PMID:33706147] [10.1016/j.ejmech.2021.113317] |
7. Yang G,Gao M,Sun Y,Wang C,Fang X,Gao H,Diao W,Yu H. (2020) Design, synthesis and anti-inflammatory activity of 3-amino acid derivatives of ocotillol-type sapogenins., 202 [PMID:32650181] [10.1016/j.ejmech.2020.112507] |
Source(1):